Особенности лечения ишемической болезни сердца на фоне железодефицитной анемии различной степени тяжести

Аннотация

Currently comorbidity is relevant in the outcome of many diseases [1]. In particular, we arc talking about 1HD, unstable angina and anemia of varying severity. In 30 patients with coronary artery disease in combination with anemia, 3-valence iron was changed, the drug Sufer (Yuria-Pharm Ukraine) at a dose of 5.0 ml iv for 5 days against the background of standard therapy. In examined patients, that an increase in hemoglobin levels contributes to the normalization of the vibros fraction reduce or disappear angina attacks, increased exercise tolerance [2,3].